Opioid Crisis Hidden Truths

BARRIERS BREACHED: DEA Annual Production Quotas

4 min · 22. maj 2026
episode BARRIERS BREACHED: DEA Annual Production Quotas cover

Description

The US drug crisis sees rising overdose deaths. We explore how DEA annual production quotas, often too lax, hinder efforts against the opioid crisis. This video examines barriers to DEA quotas, their impact on addiction treatment, and the role of law enforcement in the fentanyl crisis. We discuss neuroscience and addiction science, the devastating impact on communities, and the importance of Narcan. Understanding DEA quotas is key to a more effective system. The US military and veterans are also affected. By adapting quotas, we can better address addiction and public health.

Comments

0

Be the first to comment

Sign up now and become a member of the Opioid Crisis Hidden Truths community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

44 episodes

episode Ask the Right Questions: FDA Ombudsman and the Future of the OPIOID CRISIS artwork

Ask the Right Questions: FDA Ombudsman and the Future of the OPIOID CRISIS

The opioid crisis deeply impacts the US with rising overdose deaths fueled by fentanyl. We are tasked by the FDA with finding solutions to move past this OPIOID CRISIS!, and the FDA ombudsman plays a crucial, overlooked role. Examining opioid addiction science, brain models, and receptors can lead to solutions. Current guidelines may be insufficient, requiring bypassing bureaucracy for change. Observing near-death experiences and naloxone highlights the crisis's gravity. Rethinking our approach, with the FDA ombudsman key, combining law enforcement, neuroscience, and public health can create a future free from this crisis. Adrenaline and depression linked to addiction need a holistic approach using the latest science. FDA and CDC guidelines can form a framework for a new paradigm. The crisis's future depends on asking pertinent questions and seeking innovative solutions, with the FDA ombudsman integral.

11. juni 20263 min